Krause Kevin Michael - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 15, 2024, Krause Kevin Michael's relationship to AN2 Therapeutics, Inc. (ANTX) is Officer (Chief Strategy Officer), and currently has 31,914 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Krause Kevin Michael - Insider Non-Derivative Transactions of ANTX Common Stock
Krause Kevin Michael - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 16, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 31914 |
| Jan 10, 2024 | Sell -- (Common Stock) | 7417 | 20.14 | 1914 |
| Jan 10, 2024 | M -- (Common Stock) | 2417 | 0.42 | 4331 |
| Jan 10, 2024 | M -- (Common Stock) | 5000 | 6.6 | 9331 |
| Jan 3, 2024 | Sell -- (Common Stock) | 2583 | 20.12 | 1914 |
| Jan 3, 2024 | M -- (Common Stock) | 2583 | 0.42 | 4497 |